Blood Transfusion Diagnostic Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the blood transfusion diagnostic market looks promising with opportunities in blood grouping and disease screening. The global blood transfusion diagnostic market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic diseases and increasing demand for donor screening.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global blood transfusion diagnostic market report, please download the report brochure.
In this market, reagents & kits is the largest product of blood transfusion diagnostic, whereas blood banks is the largest end user. Growth in various segments of the blood transfusion diagnostic market are given below:
The study includes trends and forecast for the global blood transfusion diagnostic market by product, application, end use, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & KitsInstruments
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Blood GroupingDisease Screening
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsBlood Banks
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the blood transfusion diagnostic companies profiled in this report include Grifols, Immucor, Ortho Clinical Diagnostic, Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Quotient.
Lucintel forecasts that reagents & kits will remain the largest segment over the forecast period due to the repetitive purchase of these products and the availability of a wide variety of blood grouping, typing, and donor screening reagents, kits, and assays.
Within this market, blood banks will remain the largest segment by end use over the forecast period due to surge in disease screening and blood typing services.
North America will remain the largest region over the forecast period due to the presence of major companies, easy availability of various assays, and growing awareness among people about blood donations.
Features of the Global Blood Transfusion Diagnostic Market
Market Size Estimates: Global blood transfusion diagnostic market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global blood transfusion diagnostic market size by various segments, such as product, application, and end use in terms of value.Regional Analysis: Global blood transfusion diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and region for the global blood transfusion diagnostic market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global blood transfusion diagnostic market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global blood transfusion diagnostic market by product (reagents & kits and instruments), application (blood grouping and disease screening), end use (hospitals and blood banks), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global blood transfusion diagnostic market?
Q.5 What are the business risks and threats to the global blood transfusion diagnostic market?
Q.6 What are emerging trends in this blood transfusion diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this blood transfusion diagnostic market?
Q.8 What are the new developments in this blood transfusion diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this blood transfusion diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this blood transfusion diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global blood transfusion diagnostic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Reagents & Kits and Instruments), Application (Blood Grouping and Disease Screening), and End Use (Hospitals and Blood Banks)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the blood transfusion diagnostic market looks promising with opportunities in blood grouping and disease screening. The global blood transfusion diagnostic market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic diseases and increasing demand for donor screening.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global blood transfusion diagnostic market report, please download the report brochure.
In this market, reagents & kits is the largest product of blood transfusion diagnostic, whereas blood banks is the largest end user. Growth in various segments of the blood transfusion diagnostic market are given below:
The study includes trends and forecast for the global blood transfusion diagnostic market by product, application, end use, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & KitsInstruments
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Blood GroupingDisease Screening
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsBlood Banks
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the blood transfusion diagnostic companies profiled in this report include Grifols, Immucor, Ortho Clinical Diagnostic, Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Quotient.
Lucintel forecasts that reagents & kits will remain the largest segment over the forecast period due to the repetitive purchase of these products and the availability of a wide variety of blood grouping, typing, and donor screening reagents, kits, and assays.
Within this market, blood banks will remain the largest segment by end use over the forecast period due to surge in disease screening and blood typing services.
North America will remain the largest region over the forecast period due to the presence of major companies, easy availability of various assays, and growing awareness among people about blood donations.
Features of the Global Blood Transfusion Diagnostic Market
Market Size Estimates: Global blood transfusion diagnostic market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global blood transfusion diagnostic market size by various segments, such as product, application, and end use in terms of value.Regional Analysis: Global blood transfusion diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and region for the global blood transfusion diagnostic market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global blood transfusion diagnostic market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global blood transfusion diagnostic market by product (reagents & kits and instruments), application (blood grouping and disease screening), end use (hospitals and blood banks), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global blood transfusion diagnostic market?
Q.5 What are the business risks and threats to the global blood transfusion diagnostic market?
Q.6 What are emerging trends in this blood transfusion diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this blood transfusion diagnostic market?
Q.8 What are the new developments in this blood transfusion diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this blood transfusion diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this blood transfusion diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global blood transfusion diagnostic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Reagents & Kits and Instruments), Application (Blood Grouping and Disease Screening), and End Use (Hospitals and Blood Banks)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Blood Transfusion Diagnostic Market Trends and Forecast
3.3: Global Blood Transfusion Diagnostic Market by Product
3.3.1: Reagents & Kits
3.3.2: Instruments
3.4: Global Blood Transfusion Diagnostic Market by Application
3.4.1: Blood Grouping
3.4.2: Disease Screening
3.5: Global Blood Transfusion Diagnostic Market by End Use
3.5.1: Hospitals
3.5.2: Blood Banks
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Blood Transfusion Diagnostic Market by Region
4.2: North American Blood Transfusion Diagnostic Market
4.2.1: Market by Product: Reagents & Kits and Instruments
4.2.2: Market by Application: Blood Grouping and Disease Screening
4.2.3: Market by End Use: Hospitals and Blood Banks
4.2.4: The United States Blood Transfusion Diagnostic Market
4.2.5: The Canadian Blood Transfusion Diagnostic Market
4.2.6: The Mexican Blood Transfusion Diagnostic Market
4.3: European Blood Transfusion Diagnostic Market
4.3.1: Market by Product: Reagents & Kits and Instruments
4.3.2: Market by Application: Blood Grouping and Disease Screening
4.3.3: Market by End Use: Hospitals and Blood Banks
4.3.4: The United Kingdom Blood Transfusion Diagnostic Market
4.3.5: The Spanish Blood Transfusion Diagnostic Market
4.3.6: The German Blood Transfusion Diagnostic Market
4.3.7: The French Blood Transfusion Diagnostic Market
4.4: APAC Blood Transfusion Diagnostic Market
4.4.1: Market by Product: Reagents & Kits and Instruments
4.4.2: Market by Application: Blood Grouping and Disease Screening
4.4.3: Market by End Use: Hospitals and Blood Banks
4.4.4: The Chinese Blood Transfusion Diagnostic Market
4.4.5: The Indian Blood Transfusion Diagnostic Market
4.4.6: The Japanese Blood Transfusion Diagnostic Market
4.5: ROW Blood Transfusion Diagnostic Market
4.5.1: Market by Product: Reagents & Kits and Instruments
4.5.2: Market by Application: Blood Grouping and Disease Screening
4.5.3: Market by End Use: Hospitals and Blood Banks
4.5.4: Brazilian Blood Transfusion Diagnostic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by Product
7.1.2: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by Application
7.1.3: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by End Use
7.1.4: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by Region
7.2: Emerging Trends in the Global Blood Transfusion Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Blood Transfusion Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Transfusion Diagnostic Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Grifols
8.2: Immucor
8.3: Orth Clinical Diagnostic
8.4: Abbott Laboratories
8.5: Bio-Rad Laboratories
8.6: F. Hoffmann-La Roche
8.7: Quotient
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Blood Transfusion Diagnostic Market Trends and Forecast
3.3: Global Blood Transfusion Diagnostic Market by Product
3.3.1: Reagents & Kits
3.3.2: Instruments
3.4: Global Blood Transfusion Diagnostic Market by Application
3.4.1: Blood Grouping
3.4.2: Disease Screening
3.5: Global Blood Transfusion Diagnostic Market by End Use
3.5.1: Hospitals
3.5.2: Blood Banks
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Blood Transfusion Diagnostic Market by Region
4.2: North American Blood Transfusion Diagnostic Market
4.2.1: Market by Product: Reagents & Kits and Instruments
4.2.2: Market by Application: Blood Grouping and Disease Screening
4.2.3: Market by End Use: Hospitals and Blood Banks
4.2.4: The United States Blood Transfusion Diagnostic Market
4.2.5: The Canadian Blood Transfusion Diagnostic Market
4.2.6: The Mexican Blood Transfusion Diagnostic Market
4.3: European Blood Transfusion Diagnostic Market
4.3.1: Market by Product: Reagents & Kits and Instruments
4.3.2: Market by Application: Blood Grouping and Disease Screening
4.3.3: Market by End Use: Hospitals and Blood Banks
4.3.4: The United Kingdom Blood Transfusion Diagnostic Market
4.3.5: The Spanish Blood Transfusion Diagnostic Market
4.3.6: The German Blood Transfusion Diagnostic Market
4.3.7: The French Blood Transfusion Diagnostic Market
4.4: APAC Blood Transfusion Diagnostic Market
4.4.1: Market by Product: Reagents & Kits and Instruments
4.4.2: Market by Application: Blood Grouping and Disease Screening
4.4.3: Market by End Use: Hospitals and Blood Banks
4.4.4: The Chinese Blood Transfusion Diagnostic Market
4.4.5: The Indian Blood Transfusion Diagnostic Market
4.4.6: The Japanese Blood Transfusion Diagnostic Market
4.5: ROW Blood Transfusion Diagnostic Market
4.5.1: Market by Product: Reagents & Kits and Instruments
4.5.2: Market by Application: Blood Grouping and Disease Screening
4.5.3: Market by End Use: Hospitals and Blood Banks
4.5.4: Brazilian Blood Transfusion Diagnostic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by Product
7.1.2: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by Application
7.1.3: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by End Use
7.1.4: Growth Opportunities for the Global Blood Transfusion Diagnostic Market by Region
7.2: Emerging Trends in the Global Blood Transfusion Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Blood Transfusion Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Transfusion Diagnostic Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Grifols
8.2: Immucor
8.3: Orth Clinical Diagnostic
8.4: Abbott Laboratories
8.5: Bio-Rad Laboratories
8.6: F. Hoffmann-La Roche
8.7: Quotient
